Journal of Rheumatic Diseases

Download original image
Fig. 2. (A) Proportion of b- or ts-DMARDs use with respect to the SE status. The number (percentage) is marked in the middle of each bar. (B) Cumulative incidence of the initiation of b- or ts-DMARDs based on the SE status over 5 years. (C) Forest plots showing hazard ratios of b- or tsDMARD initiation in patients with RA. The Cox proportional hazards model was used to estimate hazard ratios and associated 95% confidence intervals. ACPA: anti-citrullinated protein antibody, bDMARDs: biologic disease-modifying anti-rheumatic drugs, BMI: body mass index, cDMARDs: conventional disease-modifying anti-rheumatic drugs, CRP: C-reactive protein, DM: diabetes mellitus, ESR: erythrocyte sedimentation rate, HBP: hypertension, HR: hazard ratio, RF: rheumatoid factor, SE: shared epitope, SHS: van der Heijde modified Sharp score, tsDMARDs: targeted synthetic disease-modifying anti-rheumatic drugs. *p<0.05, **p<0.01.
J Rheum Dis 2022;29:171~180
© J Rheum Dis